Ra Pharmaceuticals
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy (NCT04025632) | Ra Pharmaceuticals | 2019-11-07 |
| Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis (NCT03315130) | Ra Pharmaceuticals | 2017-10-11 |
| Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab (NCT03030183) | Ra Pharmaceuticals | 2017-04-17 |
| Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients (NCT03078582) | Ra Pharmaceuticals | 2017-03-08 |
Track Ra Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.